List View

By /

Clear

Displaying 2,801 - 2,825 of 2,995

Tumor Biology, Pathology, Novel Diagnostics

Tumor Biology, Pathology, Novel Diagnostics

ALK, ROS1, and BRAF Positive Lung Cancer

ALK, ROS1, and BRAF Positive Lung Cancer

EGFR Mutated Lung Cancer - Advanced Stage

EGFR Mutated Lung Cancer - Advanced Stage

PD-1/PD-L1 Directed Immunotherapy for Advanced NSCLC

PD-1/PD-L1 Directed Immunotherapy for Advanced NSCLC

Other Immunotherapy Targets & Agents- Advanced NSCLC

Other Immunotherapy Targets & Agents- Advanced NSCLC

Small Cell Lung Cancer

Small Cell Lung Cancer

Mesothelioma and Thymoma – Limited and Advanced Stage

Mesothelioma and Thymoma – Limited and Advanced Stage

Everything You Wanted To Know About the Pitt-Cal U54 Pharmacokinetics Resource Laboratory

Everything You Wanted To Know About the Pitt-Cal U54 Pharmacokinetics Resource Laboratory

Expansion Cohorts in Early Phase Clinical Trials: Valuable or Not?

Expansion Cohorts in Early Phase Clinical Trials: Valuable or Not?

Overview on How to Submit a Clinical Letter of Intent (LOI) to NCI/CTEP

Overview on How to Submit a Clinical Letter of Intent (LOI) to NCI/CTEP

Perioperative Therapy and Predictive Biomarkers in Early Stage Non Small Cell Lung Cancer

Perioperative Therapy and Predictive Biomarkers in Early Stage Non Small Cell Lung Cancer

Advances in Non-PD(L)1 Immunotherapies in Solid Tumors

Advances in Non-PD(L)1 Immunotherapies in Solid Tumors

Advances in Cellular Therapies for Cancer

Advances in Cellular Therapies for Cancer

Updates in the Management of Pancreatic Cancer

Updates in the Management of Pancreatic Cancer

Recent Advances in Colorectal Cancer

Recent Advances in Colorectal Cancer

New Developments in Esophageal and Gastric Cancer

New Developments in Esophageal and Gastric Cancer

Updates in Immunotherapy for Metastatic Lung Cancer

Updates in Immunotherapy for Metastatic Lung Cancer

Updates in NSCLC Targeted Therapy

Updates in NSCLC Targeted Therapy

Advances in Limited and Extensive Stage Small Cell Lung Cancer

Advances in Limited and Extensive Stage Small Cell Lung Cancer

Updates in Locally Advanced Unresectable (Stage III) NSCLC

Updates in Locally Advanced Unresectable (Stage III) NSCLC

Precision Oncology and Landmark Advances in GU Malignancies

Precision Oncology and Landmark Advances in GU Malignancies

State of the Art: Hormone-sensitive Prostate Cancer

State of the Art: Hormone-sensitive Prostate Cancer

Castration Resistant Prostate Cancer: What is the Optimal Strategy?

Castration Resistant Prostate Cancer: What is the Optimal Strategy?

Management of Renal Cell Carcinoma

Management of Renal Cell Carcinoma

Systemic Therapy in Urothelial Carcinoma

Systemic Therapy in Urothelial Carcinoma